Furthermore, BRAF/MAPK pathway blockade is represented by inhibition of tumor-associated fibroblasts (TAFs) by modulation of interleukin-1 (IL-1), in particular by the transcription of IL-1α and IL-1β [136]. The gene discussed is BRAF; the disease is neoplasm.